GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xcelerate XCRT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.02

-0.11%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

—

FY2014FY2025

Net income

−$1.2m

FY2014FY2025

Free cash flow

−$378,860

FY2014FY2025

Shareholders' equity

−$2.1m

FY2014FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2014
Revenue—$2.2m$1.1m———$4.1m
Operating income−$258,816−$1.1m−$2.6m−$844,610−$231,030−$13,250$222,060
Net income−$1.2m−$688,730−$2.8m−$844,609−$231,026−$13,249$40,881
Diluted earnings per share-0.00-0.00-0.01-0.00-0.00-0.000.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2014
Total assets$363,064$1.7m$1.9m$228,815——$2.5m
Cash and short-term investments$363,064$123,548$238,028$18,815——$13,792
Total liabilities$2.4m$2.9m$2.1m$247,199$223,775$19,645$2.3m
Debt$1.9m$2.1m$1.4m$132,067$165,313$19,645$2.0m
Shareholders' equity−$2.1m−$835,460−$166,484−$18,384−$223,775−$19,645$159,903
Shares outstanding434m434m416m405m364m434m248m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2014
Cash from operations−$378,860−$781,522−$713,087−$137,940−$145,668−$13,249−$46,461
Capital spending——−$3———−$1,041
Free cash flow−$378,860−$781,522−$713,090−$137,940−$145,668−$13,249−$47,502

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Sept 2024Jun 2024
Revenue——−$1.7m$531,921$535,423$646,509$558,000$766,329
Operating income−$54,175−$15,630$92,234−$56,732−$178,213−$116,106−$244,251−$248,120
Net income−$32,325−$15,630−$883,270−$65,347−$161,880−$107,961−$148,219−$201,513
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$219,259$328,933$363,064$1.8m$1.6m$1.6m—$1.8m
Cash and short-term investments$204,259$328,933$363,064$202,554$75,083$93,131—$110,478
Debt$1.8m$1.8m$1.9m$1.9m$2.0m$2.0m—$1.7m
Shareholders' equity−$2.1m−$2.1m−$2.1m−$1.2m−$1.1m−$943,420—−$543,964

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-32.6%81.2%—
Net income13.0%147.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-2.0-8.7-2.1-6.5-52.6-604.1
Price to sales—2.75.2———

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-38%-20%13%-50%60%12998%361%10130%124%573%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.